News & Publications

March 17, 2021

Treventis presents at the Targeting Protein Misfolding Summit

Treventis VP Research Dr. Marcia Taylor was an invited speaker at the Targeting Protein Misfolding Summit, held virtually from March...
Read More
March 15, 2021

Treventis VP Research Marcia Taylor attends AD/PD 2021

Dr. Marcia Taylor was in attendance at the virtual AD/PD conference taking that took place on March 9-14, 2021. This...
Read More
December 9, 2020

Treventis scientists and advisors attend and present at ALS/MND 2020

Treventis scientists Drs. Christopher Barden and Ross Mancini and SAB member Dr. Janice Robertson attended the 31st Virtual International Symposium...
Read More
August 1, 2020

Treventis attends Virtual AAIC 2020

Treventis was well represented at the Alzheimer Association International Conference, running from Jul 27-31, 2020 (originally scheduled for Amsterdam, the...
Read More
July 8, 2020

Treventis founders awarded funding for COVID-19 clinical trial

LifeArc, a major UK-based charity, has announced funding for Treventis founders Dr. Donald Weaver, Christopher Barden, and Mark Reed to...
Read More
June 13, 2020

Treventis attends Virtual BIO Conference

Not to be deterred by COVID-19, Treventis attended the BIO Digital International Convention (formerly scheduled for San Diego, California; instead...
Read More
February 25, 2020

Treventis attends 8th Neurodegenerative Drug Development Summit

Treventis CSO Mark Reed was in attendance at the 8th Neurodegenerative Drug Development Summit (previously known as World CNS) held...
Read More
February 12, 2020

Treventis Attends Tau2020 Conference

Treventis VP Research Marcia Taylor has attended Tau2020 in Washington, DC, which is one of the world’s biggest conferences focusing...
Read More
December 13, 2019

Treventis founders publish new computational methodology for brain drug design

Treventis founders Dr. Donald Weaver, Mark Reed, and Christopher Barden have supervised research at Toronto hospital UHN into new methods...
Read More
November 6, 2019

Treventis attends BioPort Atlantic Conference

Treventis CEO Christopher Barden attended BioPort, Atlantic Canada’s largest health and life sciences event in Halifax, Nova Scotia. BioPort is...
Read More
1 2 3